Literature DB >> 35378070

Dapagliflozin in young people with type 2 diabetes.

Kalie L Tommerdahl1, Robert G Nelson2, Petter Bjornstad3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35378070      PMCID： PMC9121802          DOI： 10.1016/S2213-8587(22)00075-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   44.867


× No keyword cloud information.
  8 in total

1.  Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.

Authors:  Elizabeth J Mayer-Davis; Jean M Lawrence; Dana Dabelea; Jasmin Divers; Scott Isom; Lawrence Dolan; Giuseppina Imperatore; Barbara Linder; Santica Marcovina; David J Pettitt; Catherine Pihoker; Sharon Saydah; Lynne Wagenknecht
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

2.  Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.

Authors:  Lorraine Levitt Katz; Barbara J Anderson; Siripoom V McKay; Roberto Izquierdo; Terri L Casey; Laurie A Higgins; Aimee Wauters; Kathryn Hirst; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2016-06-28       Impact factor: 19.112

3.  Effects of Treatment of Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes With Metformin Alone or in Combination With Insulin Glargine on β-Cell Function: Comparison of Responses In Youth And Adults.

Authors: 
Journal:  Diabetes       Date:  2019-06-09       Impact factor: 9.461

4.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245

5.  Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes.

Authors:  Helen C Looker; Laura Pyle; Tim Vigers; Cameron Severn; Pierre J Saulnier; Behzad Najafian; Michael Mauer; Robert G Nelson; Petter Bjornstad
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

6.  Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.

Authors:  William V Tamborlane; Lori M Laffel; Naim Shehadeh; Elvira Isganaitis; Michelle Van Name; Jayantha Ratnayake; Cecilia Karlsson; Ensio Norjavaara
Journal:  Lancet Diabetes Endocrinol       Date:  2022-04-01       Impact factor: 32.069

7.  Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.

Authors:  Petter Bjornstad; Lori Laffel; William V Tamborlane; Gudrun Simons; Stefan Hantel; Maximilian von Eynatten; Jyothis George; Jan Marquard; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-06-25       Impact factor: 19.112

8.  Long-Term Complications in Youth-Onset Type 2 Diabetes.

Authors:  Petter Bjornstad; Kimberly L Drews; Sonia Caprio; Rose Gubitosi-Klug; David M Nathan; Bereket Tesfaldet; Jeanie Tryggestad; Neil H White; Philip Zeitler
Journal:  N Engl J Med       Date:  2021-07-29       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.